An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

National Cancer Center Hospital East, Kashiwa-shi

Kanagawa Cancer Center, Yokohama

Seirei Hamamatsu General Hospital, Hamamatsu

Juntendo University Hospital, Bunkyō-Ku

The University of Tokyo Hospital, Bunkyō-Ku

The Cancer Institute Hospital ofJFCR, Koto-ku

Kyorin University Hospital, Mitaka-shi

Keio University Hospital, Shinjuku-Ku

National Cancer Center Hospital, Chūōku